Literature DB >> 25223464

The Yin-Yang of guidelines and disparity.

Tony Mok1.   

Abstract

Mesh：

Year:  2014        PMID： 25223464      PMCID： PMC4201003          DOI： 10.1634/theoncologist.2014-0282

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  2 in total

1.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

2.  Lung cancer treatment disparities in China: a question in need of an answer.

Authors:  Lu-Lu Yang; Xu-Chao Zhang; Xue-Ning Yang; Jin-Ji Yang; Zhen Wang; Hua-Jun Chen; Hong-Hong Yan; Chong-Rui Xu; Ji-Lin Guan; Yan-Yan He; Wen-Zhao Zhong; She-Juan An; Yi-Long Wu
Journal:  Oncologist       Date:  2014-09-15
  2 in total
  1 in total

1.  Insight into early-phase trials for lung cancer in the United States.

Authors:  Jin-Ji Yang; Yi-Long Wu
Journal:  Chin J Cancer       Date:  2015-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.